CRH Medical Corp (CRH) Stock Rating Lowered by Beacon Securities
CRH Medical Corp (TSE:CRH) was downgraded by stock analysts at Beacon Securities from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
Several other analysts have also commented on CRH. National Bank Financial lowered their price objective on shares of CRH Medical Corp from C$7.00 to C$5.25 and set an “outperform” rating on the stock in a research report on Friday. Royal Bank Of Canada lowered their price objective on shares of CRH Medical Corp from C$6.00 to C$5.00 and set an “outperform” rating on the stock in a research report on Friday. Scotiabank lowered their price objective on shares of CRH Medical Corp from C$7.00 to C$6.75 and set an “outperform” rating on the stock in a research report on Thursday, August 3rd. Bloom Burton lowered shares of CRH Medical Corp from a “buy” rating to an “accumulate” rating in a research report on Friday, July 14th. Finally, TD Securities lifted their price objective on shares of CRH Medical Corp from C$5.50 to C$10.00 and gave the stock a “hold” rating in a research report on Tuesday, July 18th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of C$6.75.
CRH Medical Corp (TSE:CRH) opened at 3.14 on Thursday. The firm has a market cap of $232.11 million and a price-to-earnings ratio of 25.74. The company has a 50-day moving average of $6.16 and a 200-day moving average of $8.46. CRH Medical Corp has a 52 week low of $3.10 and a 52 week high of $12.35.
TRADEMARK VIOLATION NOTICE: “CRH Medical Corp (CRH) Stock Rating Lowered by Beacon Securities” was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another website, it was copied illegally and republished in violation of international trademark and copyright laws. The legal version of this report can be read at https://www.americanbankingnews.com/2017/08/08/crh-medical-corp-crh-stock-rating-lowered-by-beacon-securities.html.
In other news, Director David Johnson sold 30,000 shares of CRH Medical Corp stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of C$5.67, for a total value of C$170,100.00.
CRH Medical Corp Company Profile
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.